![Direct Oral Anticoagulants Form Thrombus Different From Warfarin in a Microchip Flow Chamber System | Scientific Reports Direct Oral Anticoagulants Form Thrombus Different From Warfarin in a Microchip Flow Chamber System | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-07939-6/MediaObjects/41598_2017_7939_Fig1_HTML.jpg)
Direct Oral Anticoagulants Form Thrombus Different From Warfarin in a Microchip Flow Chamber System | Scientific Reports
East Kent Prescribing Group - Non-valvular Atrial Fibrillation- prevention of stroke and systemic embolism in adults- anticoagulation decision making tool
![Cancers | Free Full-Text | Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers Cancers | Free Full-Text | Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers](https://www.mdpi.com/cancers/cancers-14-00703/article_deploy/html/images/cancers-14-00703-g001.png)
Cancers | Free Full-Text | Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers
![Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry - Sciria - 2020 - Clinical Cardiology - Wiley Online Library Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry - Sciria - 2020 - Clinical Cardiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e2423b49-252a-4ed8-ba62-b784cbead8cb/clc23376-fig-0003-m.jpg)
Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry - Sciria - 2020 - Clinical Cardiology - Wiley Online Library
![Stroke Prevention in Atrial Fibrillation (AF) Protect and Perfect – Optimising anticoagulation treatment | NICE Stroke Prevention in Atrial Fibrillation (AF) Protect and Perfect – Optimising anticoagulation treatment | NICE](https://www.nice.org.uk/Media/Default/sharedlearning/Picture1.jpg)
Stroke Prevention in Atrial Fibrillation (AF) Protect and Perfect – Optimising anticoagulation treatment | NICE
![OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic | Open Heart OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic | Open Heart](https://openheart.bmj.com/content/openhrt/8/2/e001784/F1.large.jpg)
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic | Open Heart
Guidance for Switching from Warfarin to Direct-acting Oral Anticoagulants (DOACs) for patients with Non-Valvular - Atrial Fibril
![Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry - Sciria - 2020 - Clinical Cardiology - Wiley Online Library Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry - Sciria - 2020 - Clinical Cardiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7332f6f4-fda2-42cc-8028-8a47fcd12385/clc23376-fig-0001-m.jpg)
Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry - Sciria - 2020 - Clinical Cardiology - Wiley Online Library
RxNotes - It is important when switching between warfarin and DOACs (direct oral anticoagulation) to maintain adequate anticoagulation. 🇺🇸NOTE FOR USA: The American recommendations for switching from warfarin to rivaroxaban is INR <
![Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/7e609588-0007-4325-8cd7-f0348b6d3e49/jah35265-fig-0003.png)
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
![Atrial Fibrillation Treated with Warfarin at an Academic Medical Center: The Potential Impact of Direct Oral Anticoagulants on Future Management - ISTH Congress Abstracts Atrial Fibrillation Treated with Warfarin at an Academic Medical Center: The Potential Impact of Direct Oral Anticoagulants on Future Management - ISTH Congress Abstracts](https://abstracts.isth.org/wp-content/uploads/2020/06/p_1120_01163.jpg)
Atrial Fibrillation Treated with Warfarin at an Academic Medical Center: The Potential Impact of Direct Oral Anticoagulants on Future Management - ISTH Congress Abstracts
![Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin | Journal of the American Heart Association Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/0992a940-0eea-4999-9676-3ffafca6f241/jah36928-fig-0001.png)
Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin | Journal of the American Heart Association
Standard Operating Procedure (SOP) for switching adult patients prescribed Direct Oral Anticoagulants (DOACs) with Non- Valvular
![Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic - Thrombosis Research Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic - Thrombosis Research](https://www.thrombosisresearch.com/cms/asset/8ba2c5fe-4ca3-4e6d-9f62-cb8c9bf9c667/gr1.jpg)
Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic - Thrombosis Research
![Stroke Prevention in Atrial Fibrillation (AF) Protect and Perfect – Optimising anticoagulation treatment | NICE Stroke Prevention in Atrial Fibrillation (AF) Protect and Perfect – Optimising anticoagulation treatment | NICE](https://www.nice.org.uk/Media/Default/sharedlearning/Picture2.jpg)